Financials Nipro Corporation

Equities

8086

JP3673600007

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange Other stock markets 10:18:52 2024-04-30 pm EDT			5-day change	1st Jan Change
1,254 ^JPY	-1.76%		-0.28%	+13.23%

Apr. 12	Jefferies Adjusts Nipro’s Price Target to 1,400 Yen From 1,200 Yen, Keeps at Hold	MT
Jan. 11	Jefferies Adjusts Nipro's Price Target to 1,200 Yen From 1,000 Yen, Keeps at Hold	MT

Valuation

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	233,067	207,297	218,061	167,011	166,195	208,111	-	-
Enterprise Value (EV) ¹	638,765	639,458	665,623	636,521	672,257	715,096	719,070	717,717
P/E ratio	19.4 x	-16.9 x	15.3 x	12.4 x	36.3 x	13.8 x	12.3 x	10.8 x
Yield	1.96%	1.06%	2.09%	2.64%	2.16%	2.61%	2.95%	3.45%
Capitalization / Revenue	0.55 x	0.47 x	0.48 x	0.34 x	0.3 x	0.35 x	0.33 x	0.32 x
EV / Revenue	1.5 x	1.45 x	1.46 x	1.29 x	1.23 x	1.21 x	1.15 x	1.09 x
EV / EBITDA	10.2 x	9.37 x	9.47 x	9.09 x	10.1 x	8.46 x	7.63 x	7.11 x
EV / FCF	-27.4 x	-23.3 x	31.7 x	-62.3 x	-11 x	-62.1 x	-42.1 x	194 x
FCF Yield	-3.66%	-4.29%	3.16%	-1.61%	-9.12%	-1.61%	-2.38%	0.52%
Price to Book	1.44 x	1.39 x	1.35 x	0.9 x	0.81 x	0.93 x	0.89 x	0.84 x
Nbr of stocks (in thousands)	163,098	163,097	163,097	163,097	163,097	163,096	-	-
Reference price ²	1,429	1,271	1,337	1,024	1,019	1,276	1,276	1,276
Announcement Date	5/9/19	5/11/20	5/11/21	5/11/22	5/11/23	-	-	-

¹JPY in Million²JPY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	426,399	442,516	455,559	494,789	545,199	592,073	627,443	655,826
EBITDA ¹	62,451	68,245	70,253	70,046	66,472	84,521	94,195	100,883
EBIT ¹	23,827	26,420	27,627	23,882	17,729	29,217	34,924	38,786
Operating Margin	5.59%	5.97%	6.06%	4.83%	3.25%	4.93%	5.57%	5.91%
Earnings before Tax (EBT) ¹	21,233	-10,158	17,519	23,243	16,777	26,737	29,713	33,545
Net income ¹	12,136	-12,281	14,209	13,455	4,574	15,135	16,936	19,278
Net margin	2.85%	-2.78%	3.12%	2.72%	0.84%	2.56%	2.7%	2.94%
EPS ²	73.68	-75.30	87.12	82.50	28.05	92.44	103.5	117.7
Free Cash Flow ¹	-23,350	-27,424	21,022	-10,220	-61,342	-11,510	-17,100	3,700
FCF margin	-5.48%	-6.2%	4.61%	-2.07%	-11.25%	-1.94%	-2.73%	0.56%
FCF Conversion (EBITDA)	-	-	29.92%	-	-	-	-	3.67%
FCF Conversion (Net income)	-	-	147.95%	-	-	-	-	19.19%
Dividend per Share ²	28.00	13.50	28.00	27.00	22.00	33.33	37.67	44.00
Announcement Date	5/9/19	5/11/20	5/11/21	5/11/22	5/11/23	-	-	-

¹JPY in Million²JPY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March	2020 S1	2021 S1	2022 Q2	2022 S1	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 S1	2023 Q3	2023 Q4	2023 S2	2024 Q1	2024 Q2	2024 S1	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales	222,668	222,254	124,119	242,120	127,236	125,433	127,892	132,447	260,339	145,962	138,898	-	140,594	145,271	285,865	153,270	-	148,870	153,570	162,618	155,592
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	12,772	14,533	7,346	12,863	6,872	4,147	2,954	3,417	6,371	6,808	4,550	-	7,337	6,151	13,488	8,874	-	-	-	-	-
Operating Margin	5.74%	6.54%	5.92%	5.31%	5.4%	3.31%	2.31%	2.58%	2.45%	4.66%	3.28%	-	5.22%	4.23%	4.72%	5.79%	-	-	-	-	-
Earnings before Tax (EBT)	9,921	9,508	-	12,120	6,973	-	9,008	-	13,145	1,579	-	-	9,368	8,087	17,455	4,627	-	-	-	-	-
Net income ¹	5,886	5,473	4,003	7,303	3,735	2,417	5,275	977	6,252	710	-	-	4,099	5,832	9,931	2,698	-427.7	4,460	3,520	4,490	2,752
Net margin	2.64%	2.46%	3.23%	3.02%	2.94%	1.93%	4.12%	0.74%	2.4%	0.49%	-	-	2.92%	4.01%	3.47%	1.76%	-	3%	2.29%	2.76%	1.77%
EPS ²	36.09	33.56	-	44.78	22.90	-	32.35	-	38.34	4.350	-	-	25.14	35.75	60.89	16.55	-2.622	-	-	-	-
Dividend per Share ²	13.50	10.50	-	14.50	-	-	-	-	13.50	-	-	8.500	-	-	10.00	-	17.00	-	16.50	-	16.50
Announcement Date	11/7/19	11/9/20	11/9/21	11/9/21	2/8/22	5/11/22	8/9/22	11/9/22	11/9/22	2/8/23	5/11/23	5/11/23	8/9/23	11/9/23	11/9/23	2/8/24	-	-	-	-	-

¹JPY in Million²JPY

Estimates

Balance Sheet Analysis

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	405,698	432,161	447,562	469,510	506,062	506,986	510,959	509,606
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	6.496 x	6.332 x	6.371 x	6.703 x	7.613 x	5.998 x	5.424 x	5.051 x
Free Cash Flow ¹	-23,350	-27,424	21,022	-10,220	-61,342	-11,510	-17,100	3,700
ROE (net income / shareholders' equity)	7.3%	-7.9%	9.2%	7.8%	2.3%	7.31%	7.45%	8.05%
ROA (Net income/ Total Assets)	2.68%	2.79%	3.12%	3.09%	1.57%	1.55%	1.55%	1.65%
Assets ¹	452,464	-439,930	456,053	435,293	291,758	976,454	1,092,618	1,168,374
Book Value Per Share ²	990.0	912.0	987.0	1,136	1,265	1,374	1,440	1,518
Cash Flow per Share ²	288.0	162.0	331.0	348.0	312.0	444.0	456.0	448.0
Capex ¹	64,394	64,670	78,861	96,793	102,633	74,610	66,935	58,325
Capex / Sales	15.1%	14.61%	17.31%	19.56%	18.82%	12.6%	10.67%	8.89%
Announcement Date	5/9/19	5/11/20	5/11/21	5/11/22	5/11/23	-	-	-

¹JPY in Million²JPY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Nipro Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,276 JPY

Average target price

1,475 JPY

Spread / Average Target

+15.60%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NIPRO CORPORATION	+13.37%	1.31B
ABBOTT LABORATORIES	-3.72%	186B
MEDTRONIC PLC	-2.60%	107B
BECTON, DICKINSON AND COMPANY	-3.79%	67.44B
DEXCOM, INC.	+2.66%	50.03B
CENCORA, INC.	+16.39%	47.81B
HOYA CORPORATION	+3.97%	41.03B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.38%	26.85B
WEST PHARMACEUTICAL SERVICES, INC.	+1.52%	25.82B
ZIMMER BIOMET HOLDINGS, INC.	-1.17%	25.01B

Other Medical Equipment, Supplies & Distribution